Fasting Blood Glucose Test: What You Need to Know Before, During, and After
A blood test measuring 17-hydroxyprogesterone levels 10 minutes after ACTH stimulation to evaluate adrenal gland function and diagnose adrenal hormone disorders.
{"This test measures how your adrenal glands respond to ACTH hormone stimulation","It helps diagnose congenital adrenal hyperplasia (CAH) and adrenal insufficiency","A small blood sample is taken before and 10 minutes after receiving synthetic ACTH","Results are compared to normal ranges to determine if adrenal function is normal"}
Key facts at a glance
- LOINC
- 77649-2
- Short code
- 17-OHP-STIM
- Synonyms
- 17OHP 10M p chal SerPl-sCnc
- Category
- chemistry
- Sample
- serum
- Container
- Serum Separator Tube (SST) or Plain Red Top Tube
- Units
- N/A
- Ref low
- 0.6
- Ref high
- 10
- Critical range
- — – 100 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 0–120 years
- Method
- Chemiluminescent Immunoassay (CLIA)
- CPT
- 83498
- SNOMED
- 30891008
- Specimen volume
- 1.0 mL minimum (2.0 mL preferred)
- Stability
- Room temperature: 24 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C): 30 days
- Hemolysis max
- 50
- Lipemia max
- 100
- Icterus max
- 40
- TAT
- 24–72 hours
- Order
- routine
What is this test? A fasting blood glucose test measures the amount of sugar (glucose) in a sample of your blood after you have not eaten for at least 8 hours. Glucose is your body's main source of energy, and this test shows how well your body is managing the amount of sugar in your bloodstream.
The 17-Hydroxyprogesterone (17-OHP) challenge test measures the level of 17-hydroxyprogesterone in your blood before and after stimulation with adrenocorticotropic hormone (ACTH). ACTH is a hormone produced by the pituitary gland that tells your adrenal glands to make cortisol and other hormones. By measuring 17-OHP levels 10 minutes after ACTH administration, doctors can assess how well your adrenal glands are functioning and detect certain hormonal disorders.
Why is this test performed? Doctors use this test to screen for diabetes or prediabetes, to monitor blood sugar control if you have already been diagnosed with diabetes, and to help investigate symptoms such as increased thirst, frequent urination, unexplained fatigue, or blurred vision.
This test is primarily used to: (1) Diagnose congenital adrenal hyperplasia (CAH), a genetic condition affecting adrenal hormone production, (2) Evaluate adrenal gland function, (3) Distinguish between different types of adrenal disorders, and (4) Monitor treatment effectiveness in patients with adrenal conditions. It is particularly useful for detecting 21-hydroxylase deficiency, the most common form of CAH.
How to prepare for the test: You will need to fast for at least 8 hours before the test, which usually means having nothing to eat or drink except water after midnight. Drinking plain water is allowed and encouraged. Keep taking your regular medications unless your doctor gives you different instructions, and tell your care team about any supplements you use.
Your doctor will provide specific instructions. Generally, you may need to fast (not eat or drink) for 8-12 hours before the test. Inform your doctor about all medications you're taking, as certain drugs like corticosteroids, sex hormones, or anti-seizure medications may affect results. Tell your doctor if you have any known adrenal conditions or have taken steroid medications recently. Wear loose-fitting clothing to allow easy access to your arm for blood draws.
What happens during the test? A trained technician will clean a small spot on your arm, wrap a band around your upper arm, and draw a small sample of blood from a vein using a thin needle. The blood draw usually takes less than five minutes, and the sample is then sent to a laboratory for analysis. You can return to your normal activities and eat afterward.
The test typically takes about 30-60 minutes. First, a healthcare professional will draw a baseline blood sample from your arm. Then, you will receive an injection of synthetic ACTH (cosyntropin). After exactly 10 minutes, another blood sample will be drawn. The injection may cause temporary flushing, increased heart rate, or a warm sensation. These effects are normal and usually subside quickly.
Understanding your results: A normal fasting glucose level is typically between 70 and 99 mg/dL. A result of 100 to 125 mg/dL suggests prediabetes, while a reading of 126 mg/dL or higher on more than one test may indicate diabetes. Your doctor will interpret your numbers together with your medical history, so be sure to ask what your specific results mean for your health.
Your results will show 17-OHP levels in the baseline and post-stimulation samples. Normal responses vary by age and sex. Significantly elevated 17-OHP levels after ACTH stimulation typically indicate congenital adrenal hyperplasia. Mild to moderate elevations may suggest other adrenal issues. Your doctor will interpret your results in context with your symptoms, medical history, and other test findings.
Are there any risks? This test is very safe. You may feel a brief sting when the needle goes in, and mild bruising or soreness at the puncture site is common. Some people feel briefly lightheaded during or after a blood draw. Serious problems are extremely rare, but contact your doctor if you notice ongoing bleeding, worsening pain, or signs of infection where the needle was inserted.
The risks are minimal and similar to routine blood tests. You may experience slight pain, bruising, or bleeding at the injection site. Some people feel dizzy or faint during or after blood draws. The ACTH injection is generally safe, though rare allergic reactions are possible. Contact your healthcare provider if you experience severe pain, persistent bleeding, signs of infection at the injection site, or unusual symptoms after the test.
Reference range
Post-ACTH stimulation (10 min): Normal response: 17-OHP typically rises significantly; Peak levels >30 nmol/L suggest congenital adrenal hyperplasia (CAH); Basal levels: 0.6-10 nmol/L (adults)N/A
No fasting required. Inform physician of current medications, especially corticosteroids, hormonal contraceptives, or anti-androgens. The ACTH stimulation test (Cosyntropin challenge) involves intravenous or intramuscular administration of synthetic ACTH (Cosyntropin) with blood draw 10 minutes after challenge
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
The 17-OHP ACTH stimulation test is clinically significant for diagnosing 21-hydroxylase deficiency in congenital adrenal hyperplasia, which is an autosomal recessive disorder causing impaired cortisol synthesis and excess androgen production. It helps differentiate between adrenal insufficiency due to primary adrenal failure versus secondary causes. The test is also valuable for detecting partial enzyme deficiencies and for screening family members of patients with CAH. Early diagnosis allows for appropriate treatment to prevent adrenal crisis and manage androgen excess symptoms.
Frequently asked questions
How long does it take to get results?
Do I need to stop my medications before the test?
Can I eat or drink before the test?
What happens if I have congenital adrenal hyperplasia?
Is the ACTH injection safe?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 10, 2026. · Read our editorial policy